Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

BLT Ramaekers; R Riemsma; F Tomini; S Deshpande; S Duffy; N Armstrong; Hans Severens; J Kleijnen; M Joore

doi:10.1007/s40273-016-0445-5

Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

BLT Ramaekers
, R Riemsma
, F Tomini
, S Deshpande
, S Duffy
, N Armstrong
, Hans Severens
, J Kleijnen
, M Joore

Health Technology Assessment (HTA)

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

43 Downloads (Pure)

Original language	English
Pages (from-to)	1-12
Number of pages	12
Journal	Pharmacoeconomics (Print)
DOIs	https://doi.org/10.1007/s40273-016-0445-5
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC NIHES-05-63-02 Quality

Access to Document

10.1007/s40273-016-0445-5

98686.pdfFinal published version, 508 KB

http://hdl.handle.net/1765/98686

Cite this

Ramaekers, BLT., Riemsma, R., Tomini, F., Deshpande, S., Duffy, S., Armstrong, N., Severens, H., Kleijnen, J., & Joore, M. (2016). Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. Pharmacoeconomics (Print), 1-12. https://doi.org/10.1007/s40273-016-0445-5

@article{eecdecc396784495b1cbf331f2eba8de,

title = "Abiraterone Acetate for the Treatment of Chemotherapy-Na{\"i}ve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal",

author = "BLT Ramaekers and R Riemsma and F Tomini and S Deshpande and S Duffy and N Armstrong and Hans Severens and J Kleijnen and M Joore",

year = "2016",

doi = "10.1007/s40273-016-0445-5",

language = "English",

pages = "1--12",

journal = "Pharmacoeconomics (Print)",

issn = "1170-7690",

publisher = "Adis",

}

Ramaekers, BLT, Riemsma, R, Tomini, F, Deshpande, S, Duffy, S, Armstrong, N, Severens, H, Kleijnen, J & Joore, M 2016, 'Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal', Pharmacoeconomics (Print), pp. 1-12. https://doi.org/10.1007/s40273-016-0445-5

TY - JOUR

T1 - Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

AU - Ramaekers, BLT

AU - Riemsma, R

AU - Tomini, F

AU - Deshpande, S

AU - Duffy, S

AU - Armstrong, N

AU - Severens, Hans

AU - Kleijnen, J

AU - Joore, M

PY - 2016

Y1 - 2016

U2 - 10.1007/s40273-016-0445-5

DO - 10.1007/s40273-016-0445-5

M3 - Article

C2 - 27566699

SN - 1170-7690

SP - 1

EP - 12

JO - Pharmacoeconomics (Print)

JF - Pharmacoeconomics (Print)

ER -